Increase in ouabain-sensitive K+-ATPase activity in hepatocellular carcinoma by overexpression of Na+,K+-ATPase α3-isoform

European Journal of Pharmacology

Volumn 638, Issue 1-3, 2010, Pages 42-46

  Shibuya, Kazuto ^a   Fukuoka, Junya ^b   Fujii, Takuto ^c   Shimoda, Eri ^c   Shimizu, Takahiro ^c   Sakai, Hideki ^c   Tsukada, Kazuhiro ^a  

^a Department of Surgery II ^*  (Japan)

^b TOYAMA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cancer; Liver; Na+,K+ ATPase; Ouabain; Overexpression

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA3 ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); OUABAIN; UNCLASSIFIED DRUG; ISOENZYME; SODIUM;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; HEPG2 CELL LINE; LIVER; LIVER TUMOR; METABOLISM;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEP G2 CELLS; HUMANS; ISOENZYMES; LIVER; LIVER NEOPLASMS; MALE; OUABAIN; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE; UP-REGULATION;

EID: 77953540591     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.029     Document Type: Article

References (23)

1. Blanco G., Mercer R.W. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. Ren. Physiol. 1998, 275:F633-F650.
2. Chiriva-Internati M., Grizzi F., Wachtel M.S., Jenkins M., Ferrari R., Cobos E., Frezza E.E. Biological treatment for liver tumor and new potential biomarkers. Dig. Dis. Sci. 2008, 53:836-843.
3. Crambert G., Hasler U., Beggah A.T., Yu C., Modyanov N.N., Horisberger J.-D., Lelièvre L., Geering K. Transport and pharmacological properties of nine different human Na,K-ATPase isozymes. J. Biol. Chem. 2000, 275:1976-1986.
4. +-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004, 43:169-175.
5. +-ATPase in lipid rafts of gastric luminal parietal cells. J. Biol. Chem. 2008, 283:6869-6877.
6. +-ATPase α1β1, α2β1 and α3β1. Eur. J. Pharmacol. 2009, 622:7-14.
7. +-ATPase is a neuronal receptor for agrin. Cell 2006, 125:359-369.
8. Khan M.I., Chesney J.A., Laber D.A., Miller D.M. Digitalis, a targeted therapy for cancer?. Am. J. Med. Sci. 2009, 337:355-359.
9. +-ATPase. Nat. Neurosci. 2007, 10:196-205.
10. Lefranc F., Mijatovic T., Kondo Y., Sauvage S., Roland I., Debeir O., Krstic D., Vasic V., Gailly P., Kondo S., Blanco G., Kiss R. Targeting the α1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 2008, 62:211-222.
11. Miao X., Liu G., Xu X., Xie C., Sun F., Yang Y., Zhang T., Hua S., Fan W., Li Q., Huang S., Wang Q., Liu G., Zhong D. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma. Cancer Genet. Cytogenet. 2008, 186:25-32.
12. Mijatovic T., Roland I., Van Quaquebeke E., Nilsson B., Mathieu A., Van Vynckt F., Darro F., Blanco G., Facchini V., Kiss R. The α1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J. Pathol. 2007, 212:170-179.
13. A-β3 expression in human hepatocellular carcinoma. Hepatology 2007, 45:735-745.
14. Prassas I., Diamandis E.P. Novel therapeutic applications of cardiac glycosides. Nat. Rev. Drug Discov. 2008, 7:926-935.
15. Rajasekaran S.A., Ball W.J., Bander N.H., Liu H., Pardee J.D., Rajasekaran A.K. Reduced expression of β-subunit of Na, K-ATPase in human clear-cell renal cell carcinoma. J. Urol. 1999, 162:574-580.
16. +-ATPase distribution in vertebrate peripheral nervous systems. J. Comp. Neurol. 2007, 500:1106-1116.
17. +-ATPase α3-isoform and down-regulation of the α1-isoform in human colorectal cancer. FEBS Lett. 2004, 563:151-154.
18. Schoner W., Scheiner-Bobis G. Endgenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 2007, 293:C509-C536.
19. Seligson D.B., Rajasekaran S.A., Yu H., Liu X., Eeva M., Tze S., Ball W., Horvath S., deKernion J.B., Rajasekaran A.K. Na, K-adenosine triphosphatase α1-subunit predicts survival of renal clear cell carcinoma. J. Urol. 2008, 179:338-345.
20. Tokusashi Y., Asai K., Tamakawa S., Yamamoto M., Yoshie M., Yaginuma Y., Miyokawa N., Aoki T., Kino S., Kasai S., Ogawa K. Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int. J. Cancer 2005, 114:39-45.
21. Woo A.L., James P.F., Lingrel J.B. Characterization of the fourth α isoform of the Na, K-ATPase. J. Membr. Biol. 1999, 169:39-44.
22. Yoda A., Hokin L.E. On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain. Biochem. Biophys. Res. Commun. 1970, 40:880-886.
23. Zhao W., Liu H., Liu W., Wu Y., Chen W., Jiang B., Zhou Y., Xue R., Luo C., Wang L., Jiang J.-D., Liu J. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Int. J. Oncol. 2006, 28:1081-1088.